16 February 2024
Semaglutide is a drug primarily prescribed by healthcare providers to treat type 2 diabetes
Hydrogenated Polyisobutene, Polybutene, Bis-Diglyceryl Polyacyladipate-2, Isostearyl Palmitate, Candelilla Cera/ Euphorbia Cerifera (Candelilla) Wax/ Cire de candelilla, Cetyl Ricinoleate, Octyldodecanol, Glyceryl Triacetyl Hydroxystearate, Synthetic Wax, Paraffin, Cera Carnauba/Copernicia Cerifera (Carnauba) Wax/Cire de carnauba, Glyceryl Triacetyl Ricinoleate, Cera Microcristallina/Microcrystalline Wax/Cire microcristalline, Persea Gratissima (Avocado) Oil, Wheat Germ Glycerides, Simmondsia Chinensis (Jojoba) Seed Oil, Helianthus Annuus (Sunflower) Seed Oil, Anthemis Nobilis Flower Extract, Rosa Canina Fruit Extract, Aloe Barbadensis Leaf Juice, Tocopherol, Tocopheryl Acetate, Tetrahexyldecyl Ascorbate, Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate, Mica, Allantoin, Sorbitan Oleate, Calcium Sodium Borosilicate, Synthetic Fluorphlogopite, Calcium Aluminum Borosilicate, Polyethylene Terephthalate, Acrylates Copolymer, Silica, Tin Oxide , Caprylyl Glycol, Flavor (Aroma), Benzyl Benzoate*
doi:10.1101/gad.14.2.142
Anti-NGF antibody injections showed great effectiveness in reducing pain but also accelerated the development of osteoarthritis, if recipients were already taking NSAIDs (241243)
Children and adolescents, unless under pediatric supervision
